Skip to content

BBIO

BridgeBio Pharma, Inc.

Key figures

MetricLast 12 months5-year CAGR
Revenue$946M+127.4%
Gross profit$892M—
Operating income−$364M—
Net income−$566M—
EPS−$3.04—
Free cash flow−$370M—